Skip to main content

Want a detailed portfolio tracker?

CERT
NASDAQ
$6.85

Certara Inc (CERT)

Certara Inc. provides software products and technology services to clients for biosimulation in drug discovery, preclinical and clinical research, regulatory filings, and market access. The company is headquartered in Princeton, New Jersey.
Website: https://www.certara.com
68 analysts
Hold
Target: $7.53 (+9.93%)

Market Cap

$1.08B

Free Cash Flow Yield

8.20%

Beta (5Y)

0.95

Price Chart

Valuation
Market Cap$1.08B
Forward P/E12.67
P/S2.62
P/B1.02
Profitability
Total Revenue (TTM)$420M
Gross Profit (TTM)$259M
EBITDA$85M
Profit Margin-8.2%
Operating Margin-4%
EPS-$0.10
Financial Health
Debt-to-Equity28.8%
Free Cash Flow Yield8.20%
Growth & Risk
EPS 5Y CAGR-21.20%
Revenue 5Y CAGR+10.67%
FCF 5Y CAGR+17.14%
Beta (5Y)0.95
Sharpe Ratio-0.36